 |
|
|
 |
|
Patient's Genes May Guide Antidepressant Use
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 | 3 "This is likely to still be a major finding in [whites] if the replications studies hold up," Carroll said. "If our findings are confirmed and if this genotyping is taken up in clinical services, then the market for SSRI drugs as first-line treatment will fall by around 50 percent. Another implication is that new drug development will shift to dual-action agents."
"The word is now out that depression is a very serious disorder with major public health and economic consequences," he continued. "There is a great deal of motivation on the professional side to do a better job of treating depression and this genetic prediction is an obvious place to start."
More information
Text Continues Below

For more on depression, visit the U.S. National Institute of Mental Health (www.nimh.nih.gov ).
Page: << Prev | 1 | 2 | 3
|
Copyright © 2006 ScoutNews, LLC. All rights reserved.
Last updated 10/3/2006
|
 |

SOURCES: Bernard Carroll, MBBS, Ph.D., scientific director, Pacific Behavioral Research Foundation, Carmel, Calif.; Julio Licinio, M.D., chairman of psychiatry, University of Miami Miller School of Medicine; Oct. 4, 2006, Journal of the American Medical Association
|